The ACR Committee on Training and Workforce is pleased to present the Virtual Rheumatology Practicum for Pediatric Rheumatology Fellows (ViP - Pediatric). This series began on July 13, 2021 and runs each Tuesday and Friday through August 6. ViP is designed for first-year fellows in training enrolled in adult fellowship programs. View the ViP program schedule for the schedule of topics, learning objectives, and materials to read in advance.
ViP - Pediatric Program Schedule and Learning Objectives
Times and speakers are subject to change.
Watch ViP - Pediatric Playlist
Registration is required to attend the live sessions and based on the different start times for each day, participants will need to register separately for Tuesday and Friday sessions.
This program is designed for educational purposes only. The material presented is not intended to represent the only or the best methods appropriate for the medical situations discussed, but rather is intended to present the opinions of the authors or presenters, which may be helpful to other practitioners. Attendees participating in this education activity sponsored by the ACR do so with full knowledge that they waive any claim they may have against the ACR for reliance on any information presented during this educational activity.
Juvenile Dermatomyositis (JDM)Kaveh Ardalan, MD, MS
In this presentation, Kaveh Ardalan, MD, MS, identifies both diagnostic features and appropriate testing for juvenile dermatomyositis. Treatment options as well potential emergencies, complications, and the severe features of JDM are also covered.
Rheumatology MedicationsErica Lawson, MD
Medication management is a critical component of patient care in pediatric rheumatology. This session provides an overview of the general principles of medication management in pediatric rheumatology, as well as the indications, dosing, side effects, and monitoring parameters for the medications used most commonly in pediatric rheumatology practice.
Aches and Pains: Common or ConcerningJennifer Weiss, MD
In her presentation, Jennifer Weiss, MD, reviews diagnostic criteria and management of juvenile fibromyalgia.
Thinking Like a Rheumatologist: LabworkCuoghi Edens, MD
Cuoghi Edens, MD, provides an overview of basic and advanced labs in the evaluation and diagnosis of a child presenting for rheumatic care. A detailed discussion of ANA and autoantibodies will be included.
The 1000 Faces of Childhood-Onset Systemic Lupus Erythematosus (SLE)Deborah Levy, MD, MS
Childhood-onset SLE is a complex autoimmune disease with protean manifestations. This session reviews the classification criteria for SLE, highlights some of the diverse presentations of childhood-onset SLE, and how ethnicity may influence disease manifestations and severity. Considerations for achieving optimal disease management, and minimizing morbidity are briefly discussed.
How to Be a Consultant + Succeeding in FellowshipJay Mehta, MD
Jay Mehta, MD, provides his personal insights on some of the lesser discussed aspects of surviving fellowship. He discusses finding your noble purpose, recognition of the ways in which fellowship differs from residency, keys to a successful mentor-mentee relationship, strategies for keeping up with pediatric rheumatology literature, a framework for teaching as a consultant, and the beauty of our small field.
History of Pediatric Rheumatology Helen Emery, MD
This session reviews the evolution of the specialty of pediatric rheumatology, emphasizing some of the important people, events, and organizations which influenced its development. The progress in basic science and its impact on current treatment will be discussed. Academic tracks and career options have changed over the years, and how that may impact current trainees will be addressed.
JIA: Biology, Classification, and Evidenced-Based ManagementPeter Nigrovic, MD
Dr. Nigrovic reviews the biology of the joint relevant for arthritis, discusses the classification and phenotype of juvenile idiopathic arthritis (JIA), and provides an evidence-based approach to four common management scenarios: early-onset oligoarthritis, severe polyarticular JIA, new-onset systemic JIA, and remission on treatment.
Succeeding in Fellowship Jay Mehta, MD
In this presentation, Jay Mehta, MD, will share his experience as a fellowship director and insights from his research on transitions through fellowship to provide strategies for not only surviving but thriving during fellowship. Attendees will come away with at least one or two strategies to help them be successful during this exciting but challenging time in their training.
Introduction to Musculoskeletal Ultrasound for Pediatric Rheumatologists Edward Oberle, MD, RhMSUS
In this presentation, Edward Oberle, MD, RhMSUS, provides a basic overview of how musculoskeletal (MSKUS) can enhance the care provided by a pediatric rheumatologist. Common ultrasonographic findings seen in juvenile idiopathic arthritis are reviewed. A brief description of opportunities for pediatric rheumatology fellows to further learn about MSKUS and develop their skills is also provided.
Amplified Pain Syndromes in the Pediatric Rheumatology ClinicWilliam Bernal, MD, MPH, RhMSUS
In this presentation, William Bernal, MD, MPH, RhMSUS, discusses the management of pediatric amplified pain syndromes using multimodal therapies. Approaches that are effective in treating amplified pain syndromes are also effective in improving the function and quality of life for pediatric patients with rheumatic disease.
Approach to Musculoskeletal RadiologyMatt Hammer, MD
In this presentation, Matt Hammer, MD, will provide an overview of imaging rheumatologic disorders from a radiology perspective. This will include how imaging can help make diagnoses and monitor the effectiveness of therapy.
Rheumatology LabsDana Gerstbacher, MD, PhD
In this presentation, Dana Gerstbacher, MD, PhD, will describe commonly used lab tests in pediatric rheumatology including inflammatory markers and autoantibodies. We will also discuss the disease associations of the autoantibodies.
Therapeutics in Pediatric Rheumatology: Essential Pharmacology for Safe and Effective PrescribingStephen Balevic, MD, MHS
In this presentation, Stephen Balevic, MD, MHS, will provide an overview of the use of biologic and non-biologic DMARDs in the treatment of pediatric rheumatic diseases, with a special emphasis on clinical pharmacology and the fundamentals for safe and effective prescribing.
Immunology BasicsEd Behrens, MD
In this presentation, Ed Behrens, MD, will discuss the immune system as it operates in health, providing a framework to understand its components and interactions. We will integrate this knowledge to understand the major patterns by which the immune systems malfunctions in disease. The learner is expected to already have a general understanding of the immune system as learned in medical school education to make the best use of this material.
Rheumatologic EmergenciesMartha Rodriguez, MD, PhD
In this presentation, Martha Rodriguez, MD, PhD, will review the approach of the most common rheumatologic emergencies that we see in practice. Clinical presentation, diagnosis and treatment approaches will be discussed.
Pediatric Scleroderma: Challenging Rare DiseasesSuzanne C. Li, MD, PhD
In this presentation, Suzanne C. Li, MD, PhD, will provide an overview of the similarities and differences between two types of pediatric scleroderma, localized scleroderma, and systemic sclerosis. The diagnosis, clinical features, and major morbidities associated with each type will be reviewed. The general approach to the evaluation and management of patients with pediatric scleroderma will be discussed.
Vasculitis (ANCA, Systemic)Marinka Twilt, MD, MScE, PhD
In this presentation, Marinka Twilt, MD, MScE, PhD, will conduct a case-based discussion about the clinical presentation of childhood ANCA-associated vasculitides. Review the differential diagnosis of pulmonary renal syndrome specifically, and review the current state of evidence for the treatment of childhood AAV.
Introduction to AutoinflammationScott Canna, MD
In this presentation, Scott Canna, MD, will use the evaluation of recurrent fevers as an entrée to the expanding world of autoinflammatory disorders. The lecture will highlight practical tips, red flags, occult symptoms, and real-time resources. However, the underlying premise is that a dynamic understanding of innate immunology is a precondition of understanding and appropriately managing suspected monogenic autoinflammatory disease.
Wolf at the Door: Childhood Onset LupusStacey Ardoin, MD, MS
In this presentation, Stacey Ardoin, MD, MS, will conduct a case-based discussion about the approach to diagnosing and treating childhood-onset SLE. Pathophysiology and long-term outcomes will also be reviewed.
Juvenile DermatomyositisStacey Tarvin, MD, MS, FAAP, FARC
Juvenile dermatomyositis (JDM), the most common chronic childhood rheumatic inflammatory muscle disease, will be discussed in this lecture. In this presentation, Stacey Tarvin, MD, MS, FAAP, FARC, will review the clinical presentation and differential diagnosis of childhood myositis. Classification criteria for idiopathic inflammatory myopathy will be discussed. Treatment approaches, prognosis and disease-related emergencies in JDM will be reviewed.
Systemic Inflammation in Children: Systemic JIA, Macrophage Activation Syndrome, and COVID-associated MIS-CGrant Schulert, MD, PhD
Pediatric rheumatologists frequently evaluate children with unexplained fever and signs of systemic inflammation. In this session, Grant Schulert, MD, PhD, will review the approach to systemic JIA, as well as the related complication macrophage activation syndrome. This session will also review the newly recognized multisystem inflammatory syndrome in children (MIS-C) temporally associated with COVID-19.
Juvenile Idiopathic ArthritisPamela Weiss, MD, MSCE
In this presentation, Pamela Weiss, MD, MSCE, covers the JIA classification schema, major clinical features of each JIA category (except systemic), initial treatment approaches, tools to assess JIA disease activity and outcomes, and an introduction to clinical trial designs for JIA.
Approach to Joint Pain; Reactive/Post-Infectious ConsiderationsT. Brent Graham, MD, MS
This presentation will cover approach to musculoskeletal pain. We will review an approach that will focus on number of joints affected and presence or absence of arthritis to help guide differential based upon categories of disease.
If you have questions about ViP Pediatric, contact Connie Herndon.